This study is, to our best knowledge, the first to investigate the prognostic role of tumour-infiltrating CD1a+, CD68+ and CD163+ and MARCO+ immune cells in periampullary adenocarcinoma, with particular reference to morphological type. This evidence concerns the gene CD68 and periampullary adenocarcinoma.